Dr. Paul Levett

The principal investigators were Henry Fraser, M.D., chairman of the department of medicine and clinical pharmacology, and Paul Levett,Ph.D., a microbiologist and former chair of the World Health Organization's Committee on Leptospirosis.
...
Currently, a team of research scientists, led by Dr. Paul Levett, is conducting an HIV genotyping study of the 43 AIDS patients who participated in the Barbados-based clinical trial.Data from these patients are being compared with those from with a control group.If the data show that "Product R" interferes with the virus' mutation or resistance to treatment, then this will provide a possible mechanism for the enhancement by Product R of the efficacy of HAART (highly active antiretroviral therapy) in AIDS.The scientists expect to publish results in peer-reviewed journals when the study is completed.

AIDS Case StudiesADVR presented case studies of AIDS patients treated with Product R at a recent conference on chemokines and chemokine receptors.Both patients in this case study presentation were initially unable to tolerate, and subsequently failed, the AIDS cocktail (HAART).

The principal investigators were Henry Fraser , M.D. , chairman of the department of medicine and clinical pharmacology , and Paul Levett , Ph.D. , a microbiologist and former chair of the World Health Organization's Committee on Leptospirosis.
...
AIDS GENOTYPING STUDY : Currently , a team of research scientists , led by Dr. Paul Levett , is conducting an HIV genotyping study of the 43 AIDS patients who participated in the Barbados-based clinical trial.Data from these patients are being compared with those from a control group.The company believes that if it is shown that Product R interferes with the virus' mutation or resistance to treatment , this will be confirmation of ADVR's hypothesis that the drug enhances the efficacy of the HAART ( highly active antiretroviral therapy ) cocktail and other treatments.The scientists expect to publish results in peer-reviewed journals when the study is completed.

AIDS CASE STUDIES : ADVR presented case studies of AIDS patients treated with Product R at a recent conference on chemokines and chemokine receptors.Both patients in this case study presentation were initially unable to tolerate , and subsequently failed , the AIDS cocktail ( HAART ).

The double-blind, randomized, placebo-controlled clinical trial is being conducted at The Queen Elizabeth Hospital, University of the West Indies School of Medicine, Barbados, by Henry Fraser, M.D., Timothy Roach, M.D., and Paul Levett, Ph.D.
...
According to a written summary of the trial by Dr. Levett, forty-three patients never previously treated with HIV anti-retroviral therapy, were enrolled in the study.
...
Fraser, Roach and Levett plan to submit the results for publication upon completion of the trial."
...
The principal investigators were Henry Fraser, M.D., chairman of the department of medicine and clinical pharmacology, and Paul Levett,Ph.D., a microbiologist and former chair of the World Health Organization's Committee on Leptospirosis.
...
Currently, a team of research scientists, led by Dr. Paul Levett, is conducting an HIV genotyping study of the 43 AIDS patients who participated in the Barbados-based clinical trial.Data from these patients are being compared with those from with a control group.

The double-blind, randomized, placebo-controlled clinical trial is being conducted at The Queen Elizabeth Hospital, University of the West Indies School of Medicine, Barbados, by Henry Fraser, M.D., Timothy Roach, M.D., and Paul Levett, Ph.D.
...
According to a written summary of the trial by Dr. Levett, forty-three patients never previously treated with HIV anti-retroviral therapy, were enrolled in the study.
...
Fraser, Roach and Levett plan to submit the results for publication upon completion of the trial."
...
The principal investigators were Henry Fraser, M.D., chairman of the department of medicine and clinical pharmacology, and Paul Levett,Ph.D., a microbiologist and former chair of the World Health Organization's Committee on Leptospirosis.
...
Currently, a team of research scientists, led by Dr. Paul Levett, is conducting an HIV genotyping study of the 43 AIDS patients who participated in the Barbados-based clinical trial.Data from these patients are being compared with those from with a control group.